Hexza Corporation (3298) Fair Value & Analysis
Basic Materials · MY · Market cap 195M MYR
Fair value as of: Jun 24, 2026
Analysis
Hexza Corporation (3298) currently trades at 0.9200 MYR, while our model-based Fair Value estimate is 0.1800 MYR — implying the stock looks roughly 80.4% overvalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Hexza Corporation Berhad, an investment holding company, manufactures and sells ethanol and formaldehyde-based liquid adhesive resins in Malaysia. The company operates through five segments: Investment holding, Resins, Ethanol, Trading, and Others. It manufactures and sells formaldehyde based adhesive resins and glues for wood related industries; ethyl alcohol, liquefied carbon dioxide, and kaoliang wine. The company also engages in the property development activities; manufacture and sale of natural vinegar, and ethanol and distillers dried grains with solubles; and marketing and distribution of consumer products and industrial chemicals. The company was formerly known as Norsechem (M) Sdn. Bhd. and changed its name to Hexza Corporation Berhad in July 1986. Hexza Corporation Berhad was incorporated in 1969 and is based in Ipoh, Malaysia.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Hexza Corporation (3298) undervalued?
What is the fair value of 3298?
What is the quality score of 3298?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.